Radial Shockwave Therapy (RSWT), also known as Extracorporeal Shockwave Therapy (ESWT), is a non-invasive treatment commonly used to address tendinopathy, including conditions like plantar fasciitis, Achilles tendinopathy, and tennis elbow. The success rate of RSWT for tendinopathy can vary based on factors such as the type of tendinopathy, the severity of the condition, and the treatment protocol used. However, research studies provide a general estimate of success rates:
Plantar Fasciitis: Studies suggest that RSWT has a success rate of 70% to 80% in improving symptoms and reducing pain in patients with chronic plantar fasciitis.
Achilles Tendinopathy: Success rates for RSWT in Achilles tendinopathy are reported to be around 65% to 75%, with improvements in pain and function.
Tennis Elbow (Lateral Epicondylitis): RSWT has shown a success rate of 60% to 70% for reducing pain and improving function in cases of chronic tennis elbow.
Greater Trochanteric Pain Syndrome: Studies typically report a success rate ranging from 60% to 80% for RSWT in treating GTPS.
Rotator Cuff Tendinopathy: Many studies report that 60% to 80% of patients experience significant improvements in pain, function, and mobility following RSWT for rotator cuff tendinopathy.
Patella Tendinopathy: The success rate of RSWT for patellar tendinopathy is typically reported in the range of 65% to 85%, with most patients experiencing significant improvements in pain and function.
Overall, the average success rate across various tendinopathies treated with RSWT tends to range between 60% and 80%, depending on the specific condition and treatment parameters. However, long-term follow-up studies are often needed to evaluate sustained benefits. RSWT is typically more effective in chronic cases (lasting over 3 months) than in acute cases.
Comments